TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0

CUSIP: 89643QAB4

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Debt / NOTE 4.000% 4/0
Market price (% of par)
73.31%
Total 13F principal
$92,690,000
Principal change
$0
Total reported market value
$67,637,000
Number of holders
2

Quarterly Holders Quick Answers

What is CUSIP 89643QAB4?
CUSIP 89643QAB4 identifies 89643QAB4 - TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q3 2021

As of 30 Sep 2021, TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 was held by 2 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $92,690,000 in principal (par value) of the bond. The largest 2 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC and STONEHILL CAPITAL MANAGEMENT LLC. This page lists 2 institutional bondholders reporting positions for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.